So like I said 70-100 million market cap. This isn’t a 10 million market cap with 10 million in funding. AGN is 18 months ahead to be exact so like I said phase 2 starts next year in the middle of the year. But drug is de risked come GLP and phase 1 as all pre clinical and studies over the past decade already de risk this drug. Again going to run either way
AGN was a 100 million market cap 2 years ago and to price EV of 0 for NYR is laughable. Just to let you know I’m comfortable and will still be here come FDA and still be here come phase 2 middle of next year and still accumulated more today
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)